StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price target on the […]